QUESTLAB logo

Quest Laboratories Limited

QUESTLAB·NSE·
₹92.20▼ -1.80 (-1.91%)
Market Cap151.09 Cr
PE Ratio10.07
Volume13,200
Day High - Low93.00 - 90.00
52W High-Low152.60 - 68.60

Quest Laboratories Limited (QUESTLAB): company summary

The company's annual revenue rose 7.5% to ₹112 crore, while annual net profit increased 7.3% to ₹15 crore.

Quest Laboratories Limited (QUESTLAB) is a micro-cap Healthcare company valued at ₹151 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Quest Laboratories Limited last traded at ₹92.2, modestly down 1.91% on the day.
Recent developments
On 2026-03-31, the company reported its latest financial results, showing a drop in quarterly revenue but an increase in net profit. Domestic institutional holding rose by 0.67 percentage points to 2.04%.
Financial performance
The company's annual revenue rose 7.5% to ₹112 crore, while annual net profit increased 7.3% to ₹15 crore. However, the latest quarter saw revenue fall 30.2% year-on-year to ₹32 crore, despite a 47.9% rise in net profit to ₹3 crore.
Valuation multiples
The stock trades at 10.1 times earnings, a discount to the Healthcare median of 32.0, 1.42 times book value.
Things to watch
The stock is 39.8% below its 52-week high. Net profit margin fell 0.0 percentage points to 13.4%. The company is not paying out dividends despite repeated profits.
Where it stands
Quest Laboratories Ltd ended the latest quarter with revenue of ₹32 crore and net profit of ₹3 crore. The stock is 39.8% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
6.8/10
Fair
Fair Value
Sign in to see
ROE
15.51%
Strong
P/E
10.07x
Cheap
Debt / Equity
0.08
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹90.00
₹93.00
52W₹68.60
₹152.60
DocStoX take

Supported by growth (10.0) and valuation (8.7), but held back by momentum (1.9). Growth looks strong at 10.0, but that is offset by momentum at 1.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.8
/10
Fair
Quality
Solid
ROE 15.5%
Valuation
Cheap
P/E 10.1×
Growth
Strong
Revenue +30.1% 5Y CAGR
Risk
Moderate
D/E 0.08
Momentum
Weak
28% of 52-week range

At a glance

Market Cap
₹151 Cr
52W High / Low
₹153 / ₹69
Dividend Yield
0.00%
Promoter Holding
66.78%
EPS (TTM)
₹9.16
Book Value
₹59.08

Key highlights

  • Profit compounding 72% a year
  • Revenue compounding 30% a year
  • Low leverage — D/E 0.08
  • Momentum is weak (1.9/10)
  • Small ₹151 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Quest Laboratories Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.